Refine by
Immune Sequencing Articles & Analysis: Older
1 news found
Today, Thermo Fisher Scientific announces a new portfolio of hematology-oncology assays for the Ion Torrent Genexus System* designed to enable a future in which turnaround times for next-generation sequencing (NGS) results can be reduced to less than 24 hours. The Oncomine Myeloid Assay GX* is the first in a series of clinical research assays available from the new suite of ...